Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia.

Long DJ 2nd, Gaikwad A, Multani A, Pathak S, Montgomery CA, Gonzalez FJ, Jaiswal AK.

Cancer Res. 2002 Jun 1;62(11):3030-6.

2.

Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity.

Iskander K, Jaiswal AK.

Chem Biol Interact. 2005 May 30;153-154:147-57. Epub 2005 Apr 7. Review.

PMID:
15935811
3.

In vivo role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue.

Gaikwad A, Long DJ 2nd, Stringer JL, Jaiswal AK.

J Biol Chem. 2001 Jun 22;276(25):22559-64. Epub 2001 Apr 17.

4.

Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis.

Iskander K, Gaikwad A, Paquet M, Long DJ 2nd, Brayton C, Barrios R, Jaiswal AK.

Cancer Res. 2005 Mar 15;65(6):2054-8.

6.

NQO1 stabilizes p53 through a distinct pathway.

Asher G, Lotem J, Kama R, Sachs L, Shaul Y.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3099-104. Epub 2002 Feb 26.

7.

Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to radiation-induced myeloproliferative disease.

Iskander K, Barrios RJ, Jaiswal AK.

Cancer Res. 2008 Oct 1;68(19):7915-22. doi: 10.1158/0008-5472.CAN-08-0766.

8.

NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells.

Siegel D, Ryder J, Ross D.

Toxicol Lett. 2001 Dec 15;125(1-3):93-8.

PMID:
11701227
9.

NQO1 and NQO2 regulation of humoral immunity and autoimmunity.

Iskander K, Li J, Han S, Zheng B, Jaiswal AK.

J Biol Chem. 2006 Oct 13;281(41):30917-24. Epub 2006 Aug 10.

10.

Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity.

Radjendirane V, Joseph P, Lee YH, Kimura S, Klein-Szanto AJ, Gonzalez FJ, Jaiswal AK.

J Biol Chem. 1998 Mar 27;273(13):7382-9.

11.

NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis.

Long DJ 2nd, Waikel RL, Wang XJ, Perlaky L, Roop DR, Jaiswal AK.

Cancer Res. 2000 Nov 1;60(21):5913-5.

12.

Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity.

Joseph P, Long DJ 2nd, Klein-Szanto AJ, Jaiswal AK.

Biochem Pharmacol. 2000 Jul 15;60(2):207-14.

PMID:
10825465
14.

Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity.

Long DJ 2nd, Iskander K, Gaikwad A, Arin M, Roop DR, Knox R, Barrios R, Jaiswal AK.

J Biol Chem. 2002 Nov 29;277(48):46131-9. Epub 2002 Sep 25.

15.

Genetic susceptibility to benzene-induced toxicity: role of NADPH: quinone oxidoreductase-1.

Bauer AK, Faiola B, Abernethy DJ, Marchan R, Pluta LJ, Wong VA, Roberts K, Jaiswal AK, Gonzalez FJ, Butterworth BE, Borghoff S, Parkinson H, Everitt J, Recio L.

Cancer Res. 2003 Mar 1;63(5):929-35.

16.
17.

Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.

Siegel D, McGuinness SM, Winski SL, Ross D.

Pharmacogenetics. 1999 Feb;9(1):113-21. Erratum in: Pharmacogenetics 1999 Jun;9(3):419.

PMID:
10208650
18.

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D.

Br J Cancer. 1997;75(1):69-75.

19.

AP-2-mediated regulation of human NAD(P)H: quinone oxidoreductase 1 (NQO1) gene expression.

Xie T, Jaiswal AK.

Biochem Pharmacol. 1996 Mar 22;51(6):771-8.

PMID:
8602872
20.

NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer.

Joseph P, Xie T, Xu Y, Jaiswal AK.

Oncol Res. 1994;6(10-11):525-32.

PMID:
7620221
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk